[PDF] Top 20 Cost of pyelonephritis in type 2 diabetes (COPID study): A cost of illness study

... P a g e 17 | 125 The urinary tract is sterile except for the distal third which contains commensal flora. This is protective to ascending infections. Individual susceptibility to urinary tract infections depends on ... See full document

... [23]. Cost per daily dose [24] of each medicine and therapy was ...negligible cost variation between the selected ...medical cost and direct non-medical cost, each participant’s responses to ... See full document

... the cost of treatment, but only two algorithms can eliminate factors that do not directly affect the cost of treatment, namely the Gradient Boost Regression and the Lasso ...of illness (0.09), ... See full document

... of diabetes can be classified into direct and indirect or intangible ...Direct cost includes hospital services, including consultation charges, laboratory tests, and the daily management of DM, which ... See full document

... by diabetes-related complica- tions on German healthcare resources, uptake of pioglitazone by patients at high risk for complications or progression of existing complications may represent an important treatment ... See full document

... treatment, cost of insulin therapy accounted for 48% of the total treatment ...treatment cost, higher than that among insulin users in western countries (range: ... See full document

... We had previously reported that glycaemic control of patients with T2D, who were examined in diabetes out- patient clinics, improved by approximately one HbA1c % unit between the years 1998 and 2006 [3]. The HbA1c ... See full document

... low cost compared with newer ...cohort study conducted in the UK, dual treatment with dipeptidyl peptidase-4 inhibitors, also called gliptins, and metformin was associated with a decreased risk in heart ... See full document

... DECODE study [8] indicated that myocar- dial infarction (MI), stroke or non-ischaemic cardiovascular disease cause 80% of deaths among patients with T2DM and over 60% of people having T2DM will develop cardio- ... See full document

... This study has several limitations common to most retrospective database ...this study used retrospective administrative claims, it was not feasible to assess the effect of an intervention ...in ... See full document

... median cost in Australia for lower extremity amputation was A$12,485, (range 6,037-24,415) (Davis, et ...our study) (see Appendix D for detailed comparative COI ...median cost in admission for ... See full document

... the cost of illnesses (COI) showed that hospitalizations due to diabetes and its complications are the main item of direct costs – reaching, for instance, 43% in the work Economic costs of diabetes ... See full document

... this study should be discussed, the most notable of which is the absence of a head-to-head clinical trial comparing cardiovascular outcomes between liraglutide and ...cotransporter 2 inhibitors, GLP-1 ... See full document

... of type 2 diabetes mellitus (T2DM) in elderly population poses many ...This study evaluated, from the health care system’s perspective, the long-term cost-effectiveness of DPP-4 ... See full document

... of illness con- sequences, duration, personal control, treatment control, symptoms, coherence, concern, emotional response, and ...your illness? The causal item was open ended to allow respondents to ... See full document

... Mark 2 (HUI-2) [10] and The Child Health Utility 9D (CHU9D) [11] were used as the measures of health outcome within the KICk-OFF ...recent study trialled the use of the EQ-5D-Y and CHU9D, although ... See full document

... be cost-effective from the societal perspective but depended on sex, age group and threshold ...The study result of 2007 [18] was that in borderline groups the cost/QALY was € 47/QALY for females and ... See full document

... Patients with focal disease who are unresponsive to first-line drugs can be treated by surgical removal of the affected area of the pancreas via a focal lesionectomy, a procedure which is usually curative [10]. Patients ... See full document

... of Type 1 diabetes, we did not include a comprehensive overhaul of diabetes monitoring and prevention in order to not overestimate and attribute costs that are also re- lated with other complications ... See full document

... cohort; 2) non-hylan G-F 20 cohort; and 3) hylan G-F 20 ...the study period or who utilized only one type of non-hylan G-F 20 HA during the study ...injection type (“3 inj”); 2) ... See full document